Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Dakin

Showing results (41-50 of 75) with videos related to

Pageof 8
Sort By:
IMJ. Illinois Medical Journal|March 1, 1970
Clinical cancer chemotherapy aimed at cellular control mechanismsF E Knock, R M Galt, Y T Oester, et al.
International Journal of Technology Assessment in Health Care|March 5, 2019
Is stratification testing for treatment of chronic obstructive pulmonary disease exacerbations cost-effective in primary care? an early cost-utility analysisLucy Abel, Helen A Dakin, Nia Roberts, et al.
Appetite|January 10, 2026
Examining the structure of visual analogue scales to capture motivation to eat in fasting and post-meal conditionsClarissa A Dakin, Cristiana Duarte, Kristine Beaulieu, et al.
European Urology|January 18, 2006
Cost-consequence analysis evaluating the use of botulinum neurotoxin-A in patients with detrusor overactivity based on clinical outcomes observed at a single UK centreVinay Kalsi, Roshni B Popat, Apostolos Apostolidis, et al.
BMJ Open|August 1, 2014
Cost-effectiveness of ranibizumab and bevacizumab for age-related macular degeneration: 2-year findings from the IVAN randomised trialHelen A Dakin, Sarah Wordsworth, Chris A Rogers, et al.
Diabetes Research and Clinical Practice|November 23, 2021
Lifetime cost-effectiveness simulation of once-weekly exenatide in type 2 diabetes: A cost-utility analysis based on the EXSCEL trialFrauke Becker, Helen A Dakin, Shelby D Reed, et al.
Bioorganic & Medicinal Chemistry Letters|June 19, 2012
Discovery of novel hedgehog antagonists from cell-based screening: Isosteric modification of p38 bisamides as potent inhibitors of SMOBin Yang, Alexander W Hird, Daniel John Russell, et al.
Health Technology Assessment (Winchester, England)|April 1, 2014
A randomised controlled trial of the clinical effectiveness and cost-effectiveness of different knee prostheses: the Knee Arthroplasty Trial (KAT)David W Murray, Graeme S MacLennan, Suzanne Breeman, et al.
The British Journal of Surgery|April 17, 2023
Cost-effectiveness of replacing versus discarding the nail in children with nail bed injuryHelen A Dakin, Thi Thu An Nguyen, Melina Dritsaki, et al.
Plos One|October 3, 2008
Evolution of the aging brain transcriptome and synaptic regulationPatrick M Loerch, Tao Lu, Kelly A Dakin, et al.
Pageof 8

Showing results (41-50 of 75) with videos related to

Sort By:
Pageof 8
IMJ. Illinois Medical Journal|March 1, 1970
Clinical cancer chemotherapy aimed at cellular control mechanismsF E Knock, R M Galt, Y T Oester, et al.
International Journal of Technology Assessment in Health Care|March 5, 2019
Is stratification testing for treatment of chronic obstructive pulmonary disease exacerbations cost-effective in primary care? an early cost-utility analysisLucy Abel, Helen A Dakin, Nia Roberts, et al.
Appetite|January 10, 2026
Examining the structure of visual analogue scales to capture motivation to eat in fasting and post-meal conditionsClarissa A Dakin, Cristiana Duarte, Kristine Beaulieu, et al.
European Urology|January 18, 2006
Cost-consequence analysis evaluating the use of botulinum neurotoxin-A in patients with detrusor overactivity based on clinical outcomes observed at a single UK centreVinay Kalsi, Roshni B Popat, Apostolos Apostolidis, et al.
BMJ Open|August 1, 2014
Cost-effectiveness of ranibizumab and bevacizumab for age-related macular degeneration: 2-year findings from the IVAN randomised trialHelen A Dakin, Sarah Wordsworth, Chris A Rogers, et al.
Diabetes Research and Clinical Practice|November 23, 2021
Lifetime cost-effectiveness simulation of once-weekly exenatide in type 2 diabetes: A cost-utility analysis based on the EXSCEL trialFrauke Becker, Helen A Dakin, Shelby D Reed, et al.
Bioorganic & Medicinal Chemistry Letters|June 19, 2012
Discovery of novel hedgehog antagonists from cell-based screening: Isosteric modification of p38 bisamides as potent inhibitors of SMOBin Yang, Alexander W Hird, Daniel John Russell, et al.
Health Technology Assessment (Winchester, England)|April 1, 2014
A randomised controlled trial of the clinical effectiveness and cost-effectiveness of different knee prostheses: the Knee Arthroplasty Trial (KAT)David W Murray, Graeme S MacLennan, Suzanne Breeman, et al.
The British Journal of Surgery|April 17, 2023
Cost-effectiveness of replacing versus discarding the nail in children with nail bed injuryHelen A Dakin, Thi Thu An Nguyen, Melina Dritsaki, et al.
Plos One|October 3, 2008
Evolution of the aging brain transcriptome and synaptic regulationPatrick M Loerch, Tao Lu, Kelly A Dakin, et al.
Pageof 8